FDA Lets Some Changes To Monitoring Tools Bypass Clearance Process During COVID-19 Pandemic
Manufacturers can expand the remote-use capabilities of patient-monitoring devices like thermometers and stethoscopes without alerting the US FDA during the coronavirus crisis, a new guidance document from the agency says.
You may also be interested in...
Manufacturers can modify 21 types of monitoring equipment to encourage remote usage during the COVID-19 pandemic without first notifying the US agency, an updated guidance document states.
US telehealth companies are seeing skyrocketing demand for devices and services, which offers opportunities and challenges during this COVID-19 crisis.
What lessons can be learned from the conviction of Theranos founder Elizabeth Holmes, found guilty on four counts of investor fraud in a US court on 4 January?